OpenAI and Sam Altman Lead $252 Million Seed Round in Merge Labs
Start here
OpenAI and its founder Sam Altman have led a $252 million seed investment in Merge Labs, a US brain-computer interface company, at a post-money valuation of $850 million. Merge Labs is developing an ultrasound-based brain-computer interface, an approach the industry describes as a third technical route, distinct from invasive approaches such as Neuralink's. The sector is seeing growing momentum on both the capital and clinical fronts. Questions that remain open include how the ultrasound route performs against invasive and other non-invasive approaches in clinical settings, and whether further capital follows into this branch of the field.
Written by a model from the reports · updated 3 hours ago
Coverage timeline
Follow the coverage to see the different angles.
- WeChatPickOpenAI and Sam Altman Lead $252 Million Investment in US Ultrasound Brain-Computer Interface Company Merge Labs
OpenAI and its founder Sam Altman led a $252 million seed round in the US brain-computer interface company Merge Labs, at a post-money valuation of $850 million. Merge Labs pursues an ultrasound brain-computer interface approach, described in the industry as a third technical route distinct from invasive approaches such as Neuralink, with momentum building on both the capital and clinical fronts.
Coverage and heat for this story
Reports so far 1·Heat now 8·Peak heat 10 (Oct 19 20:00)·Reports, 24h +1
Two panels, same clock (pointer stays in sync): top is cumulative editorial reports — only rises; last point = All reports; slope = new reports that hour. Bottom is Live-board heatIndex — 7-day participants with a 24-hour half-life, so it can fall when talk cools.